Fluphenazine Decanoate for Psoriasis

NCT00356200 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Enrollment criteria met

Conditions

Psoriasis

Interventions

DRUG: Fluphenazine Decanoate
DRUG: Placebo

Sponsor

Tufts Medical Center

Collaborators

[object Object]